FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

A clinical trial is investigating whether a stem cell-derived patch can replace disease-damaged cells and restore vision. Age-related macular degeneration is a steadily worsening eye disease and the ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

Approaching her 91st birthday, Dame Judi Dench has offered a poignant insight into her worsening eyesight, describing the decline as "crushing". The beloved actress, who was first diagnosed with ...

The CEO and founder of Science Corp discusses his company’s latest breakthrough: an ocular prosthesis, implanted with a chip under the retina ...

Instant coffee is enjoying a nostalgic comeback among younger drinkers — yet new research warns the retro favorite may pose an unexpected risk for eye health. Developed in the early 20th century and ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Participants received retinal implants that restored some of their vision. Zorica Nastasic via Getty Images Today, in the New England Journal of Medicine, researchers announced that they restored some ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...